New Breast Cancer Mannequin To Revolutionize Teaching of Breast Cancer AwarenessSeptember 29, 2003Researchers at the University of Warwick will mark the first day of Breast Cancer Awareness Month with the launch of a unique, highly accurate, breast cancer mannequin that, for the first time, will give women learning how to spot breast lumps a training aid that can closely mimic what a range of breast lumps actually look and feel like. The quest to create this unique breast cancer teaching aid began when three highly motivated disability nurses approached University of Warwick plastics engineer Dr Nick Tucker to help them create a teaching aid that would assist them in teaching breast cancer awareness and self inspection to people with learning difficulties. The final result is something that will be of great assistance to all women. The mannequin consists of a fiberglass torso, which can be fitted with 4 different interchangeable types of breast implants, all containing different tissue anomalies (lumps). The torso with the silicone rubber breast implants is covered by a latex covering of 'skin' which makes the model appear and feel true-to-life. The device enables individuals to learn self-examination. It will benefit all women but will be of particular benefit those with learning difficulties who's limited reading skills limit how much they can benefit from many current breast cancer self examination training methods. The mannequin will also be particularly useful when working with women with cultural inhibitions that otherwise impede them learning about self examination. Clinical trials are underway to investigate the use of the mannequins in a GP Surgery, a Residential Home for Learning Disability and a Cancer Treatment Centre. Early results of those trails have been very positive. The nurses and Dr Tucker have also already begun investigating the development of a similar model for testicular cancer. The mannequin will provide a unique breast cancer training experience for women - but it has already been a unique experience for Stourbridge machining company Micron Machining. Normally the company deals with metal and plastic based precision light and medium engineering but Dr Tucker and the Nurses persuaded the company to give them free use of their equipment and skilled staff to create the prototype main mannequin frames and skins to the design and concept of Dr Tucker and the Nurses. The company now hopes to get a diversification grant to allow to assist a full production run of the device. Press opportunity: There will be an opportunity to film/photograph the device and interview the key people involved in its creation at the launch of the mannequin at Micron Machining, High Street, Wordsley, Stourbridge on Wednesday 1st October at 10.30am. A selection of photographs can also be found on the web version of the press release listed at http://www.communicate.warwick.ac.uk/index.cfm?page=pressrelease&id=1313 For further details please contact: Peter Dunn, Press Officer, University of Warwick Tel: 024 76 523708 p.j.dunn@warwick.ac.uk Dr Nick Tucker Tel: 024 76 522499 The Nurses 077929 40426 PR108 26th Sept 2003 Warwick, University of |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||